Stift Carlanderska Sjukhuset

At Stift Carlanderska Sjukhuset, clinical trials in cardiovascular diseases focus on people at elevated risk of major heart and blood vessel events, including those with established risk factors but no prior heart attack or stroke. The studies are designed to test new approaches that may help prevent serious outcomes and improve long-term heart health.

• Preventing major adverse cardiovascular events in high-risk adults
• Reducing the risk of heart attack, stroke, and related complications
• Evaluating treatments for primary prevention of atherosclerotic cardiovascular disease

These trials mainly explore whether newer therapies can lower the chance of future coronary heart disease events and support better prevention strategies in patients with significant cardiovascular risk.

The site also conducts studies in nutritional and metabolic diseases, especially type 2 diabetes, obesity, and related conditions such as heart failure with preserved or mildly reduced ejection fraction. This research looks at how treatments may improve weight, blood sugar control, and broader cardiometabolic health.

• Improving outcomes in type 2 diabetes and early diabetes care
• Testing therapies for obesity and overweight with diabetes
• Studying treatments for heart failure linked to obesity and metabolic disease

Overall, the research is aimed at finding more effective ways to manage metabolic disorders while also lowering the risk of heart-related complications in people with diabetes mellitus type II and related conditions.